Inhibition of TGF-β1 in the mouse model of lymphedema can reduce extracellular matrix deposition, increase the formation of collateral lymphatic vessels, and inhibit the infiltration of T cells, which may play a role in the treatment of lymphedema (26). Here, TGFB1 is linked to lymphedema.